Notice of Report on Completion of Merger
Voronoi Inc. has completed all procedures required for the merger as prescribed by the Korean Commercial Act in absorbing and merging with B2S Bio Inc. Accordingly, the Company's Board of Directors has resolved, pursuant to Article 526, Paragraphs 1 and 3 of the Korean Commercial Act, to substitute this public notice for the general meeting of shareholders for the merger report, and hereby reports the completion of the merger to each shareholder through this notice as follows.

- Details -
1. Details of the Merger
(1) Parties to the Merger
- Surviving company: Voronoi Inc.
- Dissolving company: B2S Bio Inc.
(2) Method of Merger
By way of a small-scale merger pursuant to Article 527-3 of the Korean Commercial Act,
Voronoi Inc. absorbs and merges with B2S Bio Inc.
(3) Merger Ratio: Voronoi Inc. : B2S Bio Inc. = 1 : 0 (merger without capital increase)
2. Progress of the Merger
(1) Date of initial Board resolution deciding the merger: March 8, 2023
(2) Date of execution of the initial merger agreement: March 9, 2023
(3) Date of Board resolution on amendment of the merger agreement: March 14, 2023
(4) Date of agreement on amendment of the merger agreement: March 15, 2023
(5) Period for notice of dissent by shareholders opposing the small-scale merger: March 29, 2023 ~ April 12, 2023
(6) Date of Board resolution approving the merger in lieu of the general meeting of shareholders: April 13, 2023
(7) Creditor objection period: April 14, 2023 ~ May 15, 2023
(8) Merger date: May 16, 2023
(9) Date of Board resolution in lieu of the general meeting for the report on completion of the merger: May 16, 2023
3. Matters Concerning Creditor Protection
The creditor protection procedures under Article 527-5 of the Korean Commercial Act have been completed.


May 16, 2023
18F, Bldg. S, IT Center, 32 Songdogwahak-ro, Yeonsu-gu, Incheon, Republic of Korea
Voronoi, CEOs Hyuntae Kim and Daekwon Kim